STEPHEN HUGHES: Open Payments
NPI 1710185400 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$120,980 in 130 payments from 5 companies in 2025. Trend: 2023 $125,318 · 2024 $104,323 · 2025 $120,980
Speaker / faculty: $111,402Consulting: $4,000Travel & lodging: $2,836Food & beverage: $2,663Education: $80
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 68 | $63,232 |
| Otsuka America Pharmaceutical, Inc. | 32 | $30,301 |
| Alkermes, Inc. | 19 | $16,456 |
| ABBVIE INC. | 10 | $9,151 |
| E.R. Squibb & Sons, L.L.C. | 1 | $1,840 |
Products named: UZEDY, AUSTEDO XR, ABILIFY MAINTENA, LYBALVI, REXULTI, VRAYLAR.
Industry payments across AL — which companies pay providers there.
